HomePBIGF • OTCMKTS
add
Paradigm Biopharmaceuticals Ltd
Previous close
$0.14
Year range
$0.11 - $0.27
Market cap
158.54M AUD
Avg Volume
1.02K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
In the news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.48M | -45.24% |
Net income | -4.85M | 51.63% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.45M | 45.35% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.87M | -68.31% |
Total assets | 27.39M | -59.16% |
Total liabilities | 3.58M | -73.23% |
Total equity | 23.81M | — |
Shares outstanding | 350.36M | — |
Price to book | 2.01 | — |
Return on assets | -68.30% | — |
Return on capital | -77.80% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -4.85M | 51.63% |
Cash from operations | -7.46M | 45.60% |
Cash from investing | -23.10K | 0.00% |
Cash from financing | -62.77K | -153.17% |
Net change in cash | -7.87M | 42.99% |
Free cash flow | -4.46M | 47.53% |
About
Founded
2014
Website
